Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes.

Yang Liu Ke Zheng Yecheng Liu Huadong Zhu

Published in: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale (2020)

PCP is a fatal complication among nephrotic syndrome patients receiving immunosuppressive therapy. The CD4+ T lymphocyte count is suggested as an independent predictor of prognosis, which can be used clinically to identify patients with high risk of unfavorable outcomes.

Keyphrases

peripheral blood
type diabetes
stem cells
intensive care unit
bone marrow
insulin resistance
glycemic control
extracorporeal membrane oxygenation
acute respiratory distress syndrome
community acquired pneumonia